NCT05195385 Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study
| NCT ID | NCT05195385 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Lung Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,635 participants |
| Start Date | 2022-04-08 |
| Primary Completion | 2027-10-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,635 participants in total. It began in 2022-04-08 with a primary completion date of 2027-10-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts. The study will enroll women between 50 and 74 years old, at risk for lung cancer due to their smoking history.
Eligibility Criteria
Inclusion Criteria: * Women aged from 50 to 74 years * who had smoked at least 20 pack years and quit less than 15 years ago * Had given their consent and accepted the need for a 2-year follow-up * Affiliated to the social security system Exclusion Criteria * Presence of clinical symptoms suggesting malignancy (weight loss, hemoptysis) or ongoing infection (cough with fever) * Evolving cancer * History of lung cancer * A 2-year follow-up not possible * Chest CT scan performed within 2 years prior to inclusion
Contact & Investigator
Marie-Pierre REVEL, PhD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT05195385 clinical trial?
This trial is open to female participants only, aged 50 Years or older, up to 74 Years, studying Lung Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05195385 currently recruiting?
Yes, NCT05195385 is actively recruiting participants. Contact the research team at marie-pierre.revel@aphp.fr for enrollment information.
Where is the NCT05195385 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05195385 clinical trial?
NCT05195385 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Marie-Pierre REVEL, PhD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 2,635 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.